These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors. Shukla B, Agarwal S, Suri V, Pathak P, Sharma MC, Gupta D, Sharma BS, Suri A, Halder A, Sarkar C. Neurol India; 2009; 57(5):559-66. PubMed ID: 19934553 [Abstract] [Full Text] [Related]
6. Molecular pathogenesis of pediatric astrocytic tumors. Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T, Konishi N. Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574 [Abstract] [Full Text] [Related]
7. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Ueki K, Nishikawa R, Nakazato Y, Hirose T, Hirato J, Funada N, Fujimaki T, Hojo S, Kubo O, Ide T, Usui M, Ochiai C, Ito S, Takahashi H, Mukasa A, Asai A, Kirino T. Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559 [Abstract] [Full Text] [Related]
8. Prognostic stratification of patients with anaplastic gliomas according to genetic profile. Dehais C, Laigle-Donadey F, Marie Y, Kujas M, Lejeune J, Benouaich-Amiel A, Pedretti M, Polivka M, Xuan KH, Thillet J, Delattre JY, Sanson M. Cancer; 2006 Oct 15; 107(8):1891-7. PubMed ID: 16986124 [Abstract] [Full Text] [Related]
10. Fluorescence in situ hybridization for 1p, 19q status in a cohort of glial neoplasms. Singh VY, Chacko G, Chacko AG, Rajshekhar V. Neurol India; 2014 Oct 15; 62(1):32-6. PubMed ID: 24608451 [Abstract] [Full Text] [Related]
11. Correlation of chromosomes 1p and 19q status and expressions of O6-methylguanine DNA methyltransferase (MGMT), p53 and Ki-67 in diffuse gliomas of World Health Organization (WHO) grades II and III: a clinicopathological study. Huang L, Jiang T, Yuan F, Li GL, Cui Y, Liu EZ, Wang ZC. Neuropathol Appl Neurobiol; 2009 Aug 15; 35(4):367-379. PubMed ID: 19019173 [Abstract] [Full Text] [Related]
12. The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors. McDonald JM, See SJ, Tremont IW, Colman H, Gilbert MR, Groves M, Burger PC, Louis DN, Giannini C, Fuller G, Passe S, Blair H, Jenkins RB, Yang H, Ledoux A, Aaron J, Tipnis U, Zhang W, Hess K, Aldape K. Cancer; 2005 Oct 01; 104(7):1468-77. PubMed ID: 16088966 [Abstract] [Full Text] [Related]
13. Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q. von Deimling A, Bender B, Jahnke R, Waha A, Kraus J, Albrecht S, Wellenreuther R, Fassbender F, Nagel J, Menon AG. Cancer Res; 1994 Mar 15; 54(6):1397-401. PubMed ID: 8137236 [Abstract] [Full Text] [Related]
14. Chromosome 1p/19q status combined with expression of p53 protein improves the diagnostic and prognostic evaluation of oligodendrogliomas. Xiong J, Liu Y, Wang Y, Ke RH, Mao Y, Ye ZR. Chin Med J (Engl); 2010 Dec 15; 123(24):3566-73. PubMed ID: 22166632 [Abstract] [Full Text] [Related]
15. Clinical, histological, and immunohistochemical features predicting 1p/19q loss of heterozygosity in oligodendroglial tumors. Kim SH, Kim H, Kim TS. Acta Neuropathol; 2005 Jul 15; 110(1):27-38. PubMed ID: 15920661 [Abstract] [Full Text] [Related]
16. Genetically distinct astrocytic and oligodendroglial components in oligoastrocytomas. Qu M, Olofsson T, Sigurdardottir S, You C, Kalimo H, Nistér M, Smits A, Ren ZP. Acta Neuropathol; 2007 Feb 15; 113(2):129-36. PubMed ID: 17031656 [Abstract] [Full Text] [Related]
17. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender. Gresner SM, Rieske P, Wozniak K, Piaskowski S, Jaskolski DJ, Skowronski W, Golanska E, Sikorska B, Liberski PP. Clin Neuropathol; 2006 Feb 15; 25(1):18-24. PubMed ID: 16465770 [Abstract] [Full Text] [Related]
18. Allelic status of 1p and 19q in oligodendrogliomas and glioblastomas: multiplex ligation-dependent probe amplification versus loss of heterozygosity. Franco-Hernández C, Martínez-Glez V, de Campos JM, Isla A, Vaquero J, Gutiérrez M, Casartelli C, Rey JA. Cancer Genet Cytogenet; 2009 Apr 15; 190(2):93-6. PubMed ID: 19380026 [Abstract] [Full Text] [Related]